Published in Blood on June 01, 1999
The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol (2002) 2.09
The Ischemic Stroke Genetics Study (ISGS) Protocol. BMC Neurol (2003) 1.98
Class prediction models of thrombocytosis using genetic biomarkers. Blood (2009) 1.92
hnRNP L regulates differences in expression of mouse integrin alpha2beta1. Blood (2006) 0.94
Association of integrin alpha2 gene variants with ischemic stroke. J Cereb Blood Flow Metab (2007) 0.91
Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study. PLoS One (2012) 0.90
Association between ITGA2 C807T polymorphism and gastric cancer risk. World J Gastroenterol (2011) 0.85
Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.82
Brazilin isolated from Caesalpinia sappan L. acts as a novel collagen receptor agonist in human platelets. J Biomed Sci (2013) 0.81
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19. Expert Opin Drug Metab Toxicol (2015) 0.79
Novel α2β1 integrin inhibitors reveal that integrin binding to collagen under shear stress conditions does not require receptor preactivation. J Biol Chem (2012) 0.79
Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Arterioscler Thromb Vasc Biol (2010) 0.78
Thrombophilia, polymorphisms, and vascular disease. Mol Pathol (2000) 0.77
Genetic dissection of platelet function in health and disease using systems biology. Hematol Oncol Clin North Am (2013) 0.75
Platelet glycoproteins and fibrinogen in recovery from idiopathic sudden hearing loss. PLoS One (2014) 0.75
Genetics of ischaemic stroke in young adults. BBA Clin (2014) 0.75
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost (2006) 3.56
Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed (2001) 3.17
Recognition sequences of restriction endonucleases and methylases--a review. Gene (1985) 3.08
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet (1993) 3.03
Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem (1991) 2.39
Specificity of restriction endonucleases and methylases--a review. Gene (1986) 2.37
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost (2009) 2.14
NA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific primers. Transfusion (1995) 1.86
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet (2001) 1.80
Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost (1998) 1.79
Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost (2009) 1.73
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost (2009) 1.70
Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood (1987) 1.65
Nomenclature of human platelet antigens. Vox Sang (2003) 1.62
Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. Eur J Immunol (2001) 1.60
Ageusia as an adverse effect of phenytoin treatment. Lancet (1998) 1.59
Cloning, characterization and heterologous expression of the SmaI restriction-modification system. Nucleic Acids Res (1989) 1.52
Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood (2000) 1.52
Non-radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG); hybridization and ELISA-based detection. Nucleic Acids Res (1990) 1.52
Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood (1998) 1.51
A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thromb Haemost (2001) 1.50
IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. J Thromb Haemost (2006) 1.49
Enhancement of BOLD-contrast sensitivity by single-shot multi-echo functional MR imaging. Magn Reson Med (1999) 1.48
Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood (1993) 1.46
Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost (2005) 1.42
A deletion in the second exon of an HLA-DRB1 allele found in a DR2-negative narcolepsy patient. Hum Immunol (1993) 1.41
[Evaluation of stroke units as medical technology]. Nervenarzt (2001) 1.39
Three new restriction endonucleases MaeI, MaeII and MaeIII from Methanococcus aeolicus. Nucleic Acids Res (1984) 1.39
Factors influencing confidential unit exclusions in blood donors. Vox Sang (2009) 1.36
Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35
Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion (1994) 1.33
348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet (1989) 1.32
Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT). Eur J Neurosci (2000) 1.30
How much blood is needed? Vox Sang (2011) 1.30
Differential amygdala activation in schizophrenia during sadness. Schizophr Res (1998) 1.29
Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. J Thromb Haemost (2006) 1.28
Cloning, expression and characterization of the Sau3AI restriction and modification genes in Staphylococcus carnosus TM300. Gene (1990) 1.28
Forkhead transcription factor FOXO1A is critical for induction of human decidualization. J Endocrinol (2006) 1.19
Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am (1997) 1.16
Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab (2001) 1.16
Sensitive chemiluminescent detection of digoxigenin-labeled nucleic acids: a fast and simple protocol and its applications. Biotechniques (1992) 1.14
In situ hybridization with digoxigenin-labeled DNA of human papillomaviruses (HPV 16/18) in HeLa and SiHa cells. Biotechniques (1990) 1.14
Expression and function of VLA-alpha 2, -alpha 3, -alpha 5 and -alpha 6-integrin receptors in pancreatic carcinoma. Int J Cancer (1992) 1.13
Taking immunogenicity assessment of therapeutic proteins to the next level. Biologicals (2011) 1.12
Diaphragm correction factors for free-air chamber standards for air kerma in x-rays. Phys Med Biol (2009) 1.09
Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort. J Neurol Neurosurg Psychiatry (2006) 1.08
Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood (1997) 1.05
Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly. Acta Neuropathol (2000) 1.04
The Bra/Brb alloantigen system on human platelets. Blood (1989) 1.04
Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood (1998) 1.04
Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry (1999) 1.04
Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke (1997) 1.04
The genomic response of the ipsilateral and contralateral cortex to stroke in aged rats. J Cell Mol Med (2008) 1.02
A comparison of laparoscopy and laparotomy for the treatment of ectopic pregnancy. Obstet Gynecol (1988) 1.02
Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes. J Thromb Haemost (2008) 1.01
First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost (1999) 1.00
SgrAI, a novel class-II restriction endonuclease from Streptomyces griseus recognizing the octanucleotide sequence 5'-CR/CCGGYG-3' [corrected]. Nucleic Acids Res (1990) 1.00
Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia. Transfusion (1987) 1.00
Receptor patching and capping of platelet membranes induced by monoclonal antibodies. Blood (1986) 1.00
Gender differences in regional cerebral activity during sadness. Hum Brain Mapp (2000) 0.99
beta-Amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age. Stroke (1998) 0.98
Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time. Thromb Haemost (1997) 0.98
Non-radioactive labeling and detection of nucleic acids. II. Optimization of the digoxigenin system. Biol Chem Hoppe Seyler (1990) 0.97
Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly. Alzheimer Dis Assoc Disord (1998) 0.96
Platelet alloantibodies in transfused patients. Transfusion (2001) 0.96
CT-angiographic collateralization predicts final infarct volume after intra-arterial thrombolysis for acute anterior circulation ischemic stroke. Cerebrovasc Dis (2010) 0.95
Two new restriction endonucleases DraII and DraIII from Deinococcus radiophilus. Nucleic Acids Res (1985) 0.95
The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol (1997) 0.95
A highly sensitive, nonradioactive DNA labeling and detection system. Biotechniques (1990) 0.95
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost (2011) 0.94
Comparison of Cytobrush and cervicovaginal lavage sampling methods for the detection of genital human papillomavirus. Am J Obstet Gynecol (1989) 0.94
Purification, crystallization, and preliminary X-ray crystallographic data analysis of small heat shock protein homolog from Methanococcus jannaschii, a hyperthermophile. J Struct Biol (1998) 0.94
Emerging clinical concerns in the ageing haemophilia patient. Haemophilia (2009) 0.93
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization. J Thromb Haemost (2009) 0.92
Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia. Report of four cases and review of literature. Thromb Res (2000) 0.91
Dissociative symptoms in obsessive-compulsive dimensions. Psychopathology (2000) 0.91
Non-radioactive labeling and detection of nucleic acids. IV. Synthesis and properties of digoxigenin-modified 2'-deoxyuridine-5'-triphosphates and a photoactivatable analog of digoxigenin (photodigoxigenin). Biol Chem Hoppe Seyler (1990) 0.91
The frequencies of human neutrophil alloantigens among the Japanese population. Tissue Antigens (2012) 0.90
Neurotrophic factor S100 beta in major depression. Neuropsychobiology (2001) 0.90
Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy. J Basic Clin Physiol Pharmacol (1998) 0.90
Subjective ratings of pain correlate with subcortical-limbic blood flow: an fMRI study. Neuropsychobiology (2001) 0.90
Needs-oriented discharge planning for high utilisers of psychiatric services: multicentre randomised controlled trial. Epidemiol Psychiatr Sci (2011) 0.89
Isolated hypoglossal nerve palsy caused by carotid artery dissection the necessity of MRI for diagnosis. J Neurol (2001) 0.89
The alpha 6-integrin receptor in pancreatic carcinoma. Gastroenterology (1995) 0.89
Single amino acid substitution in human platelet glycoprotein Ibbeta is responsible for the formation of the platelet-specific alloantigen Iy(a). Blood (2000) 0.89
Transcranial power mode Doppler duplex sonography of intracranial aneurysms. J Neuroimaging (1998) 0.89
Nonradioactive labeling and high-sensitive detection of PCR products. Mol Biotechnol (1994) 0.89
Relation between psychological strain and carotid atherosclerosis in a general population. Heart (2005) 0.88
Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost (2012) 0.88
The role of junctional adhesion molecules in cell-cell interactions. Histol Histopathol (2005) 0.88
Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. J Neurol (1998) 0.88
Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies. Blood (1986) 0.88
Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies: a common occurrence. J Thromb Haemost (2007) 0.88
Workshop report on the genotyping of blood cell alloantigens. Transfus Med (2001) 0.87